- 专利标题: Vanilloid receptor ligands and their use in treatments
-
申请号: US11099978申请日: 2005-04-05
-
公开(公告)号: US20050272931A1公开(公告)日: 2005-12-08
- 发明人: Yunxin Bo , Partha Chakrabarti , Ning Chen , Elizabeth Doherty , Christopher Fotsch , Nianhe Han , Michael Kelly , Qingyian Liu , Mark Norman , Vassil Ognyanov , Xianghong Wang , Jiawang Zhu
- 申请人: Yunxin Bo , Partha Chakrabarti , Ning Chen , Elizabeth Doherty , Christopher Fotsch , Nianhe Han , Michael Kelly , Qingyian Liu , Mark Norman , Vassil Ognyanov , Xianghong Wang , Jiawang Zhu
- 专利权人: Amgen Inc.
- 当前专利权人: Amgen Inc.
- 主分类号: C07D249/18
- IPC分类号: C07D249/18 ; A61K31/17 ; A61K31/18 ; A61K31/343 ; A61K31/357 ; A61K31/36 ; A61K31/37 ; A61K31/381 ; A61K31/4025 ; A61K31/404 ; A61K31/41 ; A61K31/415 ; A61K31/4184 ; A61K31/4192 ; A61K31/423 ; A61K31/428 ; A61K31/44 ; A61K31/4402 ; A61K31/4406 ; A61K31/443 ; A61K31/444 ; A61K31/453 ; A61K31/47 ; A61K31/4704 ; A61K31/4709 ; A61K31/472 ; A61K31/496 ; A61K31/4965 ; A61K31/498 ; A61K31/505 ; A61K31/517 ; A61K31/5375 ; A61K31/538 ; A61P1/00 ; A61P1/04 ; A61P1/12 ; A61P3/10 ; A61P9/00 ; A61P11/00 ; A61P11/02 ; A61P11/06 ; A61P13/00 ; A61P13/10 ; A61P17/00 ; A61P17/02 ; A61P17/04 ; A61P17/06 ; A61P17/14 ; A61P19/02 ; A61P25/00 ; A61P25/06 ; A61P27/02 ; A61P29/00 ; A61P31/12 ; A61P37/08 ; A61P43/00 ; C07C233/11 ; C07C233/15 ; C07C233/33 ; C07C233/44 ; C07C311/13 ; C07C311/16 ; C07C317/40 ; C07C323/35 ; C07D209/08 ; C07D209/12 ; C07D209/42 ; C07D209/48 ; C07D213/26 ; C07D213/64 ; C07D213/643 ; C07D213/74 ; C07D213/75 ; C07D215/22 ; C07D215/227 ; C07D215/32 ; C07D215/38 ; C07D215/40 ; C07D215/42 ; C07D217/04 ; C07D231/40 ; C07D231/56 ; C07D233/38 ; C07D235/08 ; C07D235/26 ; C07D237/20 ; C07D239/42 ; C07D239/88 ; C07D239/90 ; C07D241/20 ; C07D241/42 ; C07D263/56 ; C07D265/36 ; C07D277/62 ; C07D277/82 ; C07D307/79 ; C07D311/16 ; C07D319/18 ; C07D319/20 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D405/14 ; C07D407/12 ; C07D409/12 ; C07D409/14 ; C07D413/12 ; C07D417/12 ; C07D417/14 ; C07D471/04 ; C07D215/16
摘要:
Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritis, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
信息查询